Abstract
INTRODUCTION
Diffusion tensor image analysis along the perivascular space (DTI-ALPS) index was proposed for assessing glymphatic clearance function. This study evaluated DTI-ALPS as a biomarker for cerebral small vessel disease (cSVD) related vascular cognitive impairment and dementia (VCID).
METHODS
Four independent cohorts were examined. A composite score of executive function (UDS3-EF) was used to evaluate EF status. The association between the ALPS index and UDS3-EF scores and the mediator effect of free water in white matter (WM-FW) on such association was analyzed.
RESULTS
The ALPS index was significantly associated with UDS3-EF scores in all cohorts. Additionally, WM-FW mediates the relationship between the ALPS index and UDS3-EF scores.
DISCUSSION
Lower ALPS index may be a surrogate marker of glymphatic dysfunction, which is associated with impaired EF, and this association is mediated by the interstitial fluid (ISF) drainage ISF in WM, providing a clinical rationale for using ALPS index as a biomarker for cSVD-related VCID.
Highlights

This is the first study to investigate the mediation role of interstitial FW fraction (WM-FW) on the relationship between glymphatic clearance (ALPS index) and EF (UDS3-EF scores) in four independent middle to aged cohorts at risk for cSVD.
This study identified that ALPS index was independently associated with UDS3-EF scores after adjusting for demographics, VRFs, and WM hyperintensity burden and that WM-FW mediated this association in all middle to aged cohorts.
Our findings suggest that in middle to aged individuals, glymphatic dysfunction (reflected by ALPS index) is strongly associated with EF and that this association is mediated by the ISF drainage in WM.
This study provides a strong clinical rationale for the use of the ALPS index as a marker of cognitive function in multi-site observational studies and clinical trials to monitor and prevent VCID.


If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.

This post is Copyright: Xiaodan Liu,
Pauline Maillard,
Giuseppe Barisano,
Arvind Caprihan,
Steven Cen,
Xingfeng Shao,
Kay Jann,
John M. Ringman,
Hanzhang Lu,
Konstantinos Arfanakis,
Charles S. DeCarli,
Brian T. Gold,
Sudha Seshadri,
Claudia L. Satizabal,
Alexa S. Beiser,
Mohamad Habes,
Joel H. Kramer,
Lara Stables,
Herpreet Singh,
Karl G. Helmer,
Steven M. Greenberg,
Danny J. J. Wang,
for the MarkVCID Consortium | December 31, 2024

Wiley: Alzheimer’s & Dementia: Table of Contents